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Introduction: dental pulp stem cells (DPSCs) have been shown to have great capacity to differentiation toward the osteoblast lineage and they can 
be considered as a great cell source for bone tissue engineering. The vitamin K family, especially vitamin K2 (MK-4), have been shown to have an 
osteoprotective role.  In this study, we have investigated the effect of various concentrations of MK-4 on differentiation of DPSCs into osteoblast. 
Materials and Methods: DPSCs were isolated and characterized to expression the mesenchymal markers. These cells were treated with osteogenic 
medium with and without of various concentrations of MK-4 for 14 days. Osteogenic capability and extracellular calcium deposition were assessed 
by ALP assay and alizarin red staining, respectively, at zero, 7, 14 days after induction. Result: the additional of MK-4 at concentration of 10 µM 
with osteogenic medium had a significant effect on differentiation DPSCs into osteoblast (P<0.05) at 14 day, as it confirmed by both ALP activity 
assay and alizarin red staining. Conclusion: MK-4 can promote differentiation of DPSCs into osteoblast in vitro so have a potential to be considered 
in improvement of cell-based bone tissue engineering therapies.  
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Introduction 
Dental pulp stem cells (DPSCs) are the mesenchymal stem cells 
(MSC) population present in adult teeth, showing similar 
features to the MSCs derived from bone marrow and adipocyte 
tissue (1). These cells have the capacity for self-renewal and the 
potential for differentiation into multiple cell lineages, 
especially osteoblasts (1-5). Also, the isolation procedure of 
DPSCs from tooth tissues is relatively non-invasive process(6). 
Previous studies have emphasized that DPSCs represent an 
excellent source for bone regeneration (3, 4, 7).  
To date, the attention of many researchers has been focused 
to enhance the osteogenic capability of MSCs for the purpose 
of the bone tissue engineering. Previous studies investigated 
the effect of various osteoinductive factors,  including bone 
morphogenetic proteins (BMPs) , dentin matrix proteins,  
transforming growth factor beta(TGF-β),  stromal cell-derived 
factor 1 (SDF-1), platelet-derived growth factor (PDGF) and  
purmorphamine,  in order to improve the osteogenic capability 
of MSCs(2, 8-12).  
Several studies have been shown that the Vitamin K as 
group of fat-soluble vitamins, is essential for blood coagulation 
as well as bone formation and remodeling in mammals (13-
17). Vitamin K naturally occurs in two forms: phyloquinones 
(K1) and menaquinines (K2) (18-20). The most common form 
of K2, menaquinine 4 (MK4), has a greater osteoprotective 
effect (19). Studies have been demonstrated that MK4 has great 
importance in inhibition of prostaglandin E2 synthesis, 
apoptotic cell death of osteoblast and also enhances human 
osteoblast-induced mineralization with or without 
coincubation with 1, 25-hydroxyvitamin D3 [1, 25(OH)2D3] 
and maintain bone strength via the ɤ-carboxylation of 
osteocalcin(13, 16, 18, 21, 22). 
In the present study, we tend to answers the question that 
whether MK4 stimulates differentiation of DPSC to osteoblast 
in vitro.  
Materials and Methods 
Dulbecco’s modified Eagle’s medium (DMEM), Fetal Bovine 
Serum (FBS), Penicillin Streptomycin (pen/strep), 
Amphotericin B and Trypsin/EDTA were purchased from 
(Life Technologies, California, United States,  and Cell Lysis 
Reagent (C3228), Alkaline Phosphatase Yellow (pNPP) Liquid 
Substrate (P7998), Alizarin Red (A3757), DAPI, β-Glycerol 
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phosphate disodium salt pentahydrate, acid ascorbic and 
dexamethasone  from Sigma-Aldrich, St. Louis, Missouri, 
United States. 
Human dental pulp extraction and cell culture 
Human dental pulp were isolated from third molar of healthy 
volunteer adult donors without systemic and oral infection or 
diseases. The inform consent forms were obtained from patients. 
Tooth were placed in sterile phosphate buffered saline (PBS) 
containing 5% pen strep. Dental pulp was obtained with a 
dentinal excavator or a Gracey curette. The pulp was immersed 
in a digestive solution composed of 3mg/ml type I collagenase at 
37C for 60 minutes. Standard medium (DMEM-high glucose 
(HG) with 15% FBS was added to the cells before the suspension 
was centrifuged at room temperature (RT) for 5 minutes at 300g. 
The cell pellet was suspended in DMEM-HG with 15% FBS and 
1% pen strep and placed in 25 cm2 flasks. Cells were maintained 
in a humidified atmosphere under 5% CO2 at 37C and media 
were changed twice a week. When DPSC reached 70% 
confluence, they were detached using 0.25% trypsin/1mM 
EDTA.  
Characterization of DPSCs 
DPSCs were characterized for the expression of MSCs markers, 
CD73, CD90, CD105 and CD44, and the weak expression for 
CD34 and CD45. At P3, DPSCs were treated with 0.05% trypsin-
EDTA. The harvested cells are centrifuged and then, cell pellet 
was re-suspended at concentration of 106 per sample in PBS and 
incubated for 30 min at room temperature in the dark with 
antibodies. After incubation time, cells were washed with PBS. 
Analysis was performed using flow cytometer. 
Osteogenic differentiation induction  
Cells were incubated triplicate in wells of a 24- well plate (5×103 
cells/well) in osteogenic medium (DMEM-Low Glucose 
containing 10% FBS, β-Glycerol phosphate disodium salt 
pentahydrate (200µg/µl), acid ascorbic (10µg/µl),dexamethasone 
(1µg/µl), 1% pen strep antibiotic) in the presence or absence of 
various concentrations of MK-4 (15, 10, 5 µM) for 14 day. 
Medium were replaced at twice a week. Cells were evaluated for 
osteogenic capability and the extracellular calcium deposition by 
alkaline phosphatase (ALP) activity assay and alizarin red 
staining, respectively, after 7 and 14 day induction. 
Quantitative ALP activity assay 
For ALP activity assay, cells were rinsed with PBS buffer and 
homogenized in Cell Lysis Reagent for 30 min with gentle 
agitation. The resulting mixture in then centrifuged at 20.000g 
for 20 min at 4°C. The cell lysate was mixed with Alkaline 
Phosphatase Yellow (pNPP) Liquid Substrate solution, after 
incubation at room temperature for 30 min, the above mixture 
is added to 1 N NaOH to stop the reaction and the absorbance 
at 405 nm was measured using ELISA reader. 
Alizarin Red staining 
For staining, the cell culture were fixed in cold 4% 
paraformaldehyde (PFA) for 20 minutes and rinsed with PBS 
buffer cells were stained with 2% alizarin red solution buffered 
at a pH of 4.2 for 20 minutes, then cells were rinsed by PBS 
buffer and observed under an inverted microscopy.  
Statistical analysis 
The results were obtained from the triplicate samples. Data 
were expressed as mean ±SD. Statistical analysis was carried 
out using SPSS V16.0 software  by one-way ANOVA followed 
by the Tukey’s multiple comparison test. P<0.05 was 
considered statistically significant. 
Results 
MSCs phenotype of DPSCs 
To ensure that the DPSCs have minimal criteria to be called 
MSCs. The DPSCs were analyzed by flow cytometry to 
monitor the surface marker profile. These cells showed high 
expression level of markers, CD44, CD73, CD90, and CD105. 
As expected, CD34 and CD45 detected on low expression 
level (Error! Reference source not found.).  
Effect of MK-4 on ALP activity 
ALP activity assay was used as an early maker of osteogenic 
differentiation. We compared ALP activity level between 
DPSCs induced to osteoblast with and without the presence of 
various concentrations of MK-4 (15, 10, 5 µM) at 0, 7 and 14 
day. There was a statistically significant change in ALP activity 
level in all groups at 14 day as it compared to 7day. These 
results showed that cells induced by osteogenic medium with 
10µM MK-4 had a high level of ALP activity compared to other 
groups. 
Effect of MK-4 on extracellular calcium deposition 
The extracellular calcium deposition, as a marker of the late 
stage of osteogenesis, was stained by alizarin red staining. All 
group demonstrated a high level of calcium deposition relative 
to 7day. Also significantly, osteogenic medium with 10µM 
MK-4 had high osteogenic efficacy at 14 day compared to other 
groups.  
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Figure 1.Alkaline Phosphatase (ALP) activity was measured using the 
p-nitrophenyl phosphate assay. Statistical significance of the differences 
between the results are indicated (* P<0.05) 
Discussion 
Previous studies have reported that enhancement of 
osteogenesis of MSCs in vitro is a vital factor in bone tissue 
engineering (23). DPSCs with a great potential to differentiation 
toward the osteoblast have been to have a capacity to use for 
bone tissue engineering in clinical setting (1, 3, 5). Some studies 
have indicated that MK-4 intake accelerates bone loss in human 
and animal models (24-27), also in vitro studies have confirmed 
a role of MK-4 as an osteoprotective factor (16, 18-20). In the 
current study, we evaluated the osteoinductive effect of MK-4 on 
differentiation DPSCs to osteoblast in vitro. Results of ALP 
activity and calcium deposition have been shown that MK-4 can 
enhancement of osteoblast differentiation. 
In present study, we evaluated the effect of various 
concentrations of MK-4 (5, 10, 15 µM) on differentiation DPSCs 
into osteoblast for 14 day in vitro. ALP assay and alizarin red 
staining have shown that 10 µM concentration of vitamin K2, 
significantly increased differentiation DPSC to osteoblast in 
compared to other groups. Similar to our observation, Igarashi 
et al. reported that 10µM of MK4 promoted gene expression of 
Msx2, as osteoblastogenic factors, in osteoblast cell line 
(MC3T3-E1) (19). Y Koshihara et al. evaluated the effect of 
different concentration of vitamin K1 and K2 from 1.0 µM to 
10µM on osteoblastogenesis and osteoclastogenesis and they 
also suggested that 10µM of MK-4 can induce the differentiation 
of mononuclear cells isolated from human bone marrow to 
osteoblast. Also, they showed that this concentration decreased 
osteoclast formation from bone marrow cells by an increase in 
cell death(20). Atkins et  
Table 1. DPSCs surface marker expression, assessed by flow 
cytometry analysis 








al showed that 10µM of MK-4  promotes mineralization, 
osteoblast-to-osteocyte transition on MLO-Y4 cells(18). In this 
study, we evaluated the osteogenic effect of MK-4 on MSCs 
derived from dental pulp. In contrast, all other reported studies 
have conducted on osteoblast cell line. However, cell lines are 
not proper for evaluation of osteoinduction since, they are 
mature and terminally differentiation.  
The above mentioned studies confirm our results for the 
effect of MK-4 on differentiation into osteoblast. Nevertheless, 
further studies are needed to investigating the effect of MK-4 on 
gene expression involved in differentiation into osteoblast and 
evaluation of differentiation peripheral blood mononuclear cell 
into osteoclast, as the main factor in bone tissue regeneration.  
Conclusion 
This study shows that MK-4 can promote differentiation of 
DPSCs towards the osteoblast in vitro, hence it can be suggested 
to be used in cell-based bone tissue engineering therapies for 
bone regeneration enhancement. 
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